drug
as of 2026-07-01AVP-786
at a glance
small molecule
Pre-approval / investigational in the US
2 trials in the graph
Synthesized from structured facts only — each point cited above.
Mechanism & identity
Modality
small molecule
Indications
Investigational (via trials)
Trials
2
Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Negative Symptoms of Schizophrenia
NCT03896945Phase 2, Phase 3Terminated
Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Residual Schizophrenia
NCT02477670Phase 2Completed
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
trial
indication
indication
indication